Lishi Pharmaceutical: Net profit in 2025 was 418 million yuan, a year-on-year increase of 126.72%.

Li Sheng Pharmaceutical released its performance report, achieving a total operating income of 1.393 billion yuan in 2025, a year-on-year increase of 4.23%; net profit of 418 million yuan, a year-on-year increase of 126.72%. The company's total profit in 2025 was 456 million yuan, an increase of 111.36% compared to the same period last year. The company actively explored the market, expanded product sales, and was also affected by the dividend from the company in which it holds shares, leading to a significant increase in total profit and net profit attributable to shareholders of the listed company. In 2025, the net profit attributable to shareholders of the listed company, after deducting non-recurring gains and losses, was 169 million yuan, an increase of 64.16% compared to the same period last year.